DSM announces retirement of president and CEO DNP Chris Goppelsroeder

DSM has announced that Chris Goppelsroeder, president and CEO DSM Nutritional Products (DNP), will retire and leave the company, effective 1 April 2021.

DSM co-CEO and COO, Dimitri de Vreeze, will step into Goppelsroeder’s DNP leadership role.

Goppelsroeder – who is also currently a member of the DSM executive committee – first joined the company in 2003 when DSM acquired Roche Holding’s vitamins division.

As president and CEO DNP since 2013, Goppelsroeder is said to have been ‘instrumental’ in the growth of DSM’s largest business, organically as well as through acquisitions. This includes DSM’s purchase of Danish HMO supplier Glycom in a €765 million deal that was announced early last year.

In addition, Goppelsroeder has reportedly played a ‘crucial role’ in DSM’s recent moves in the precision and personalised nutrition space, and in the development of big innovation projects.

DSM co-CEOs, Geraldine Matchett and Dimitri de Vreeze, said: “Chris has been a key and valued leader for DSM and we are very grateful for his dedication and the contributions he has made in transforming DSM to where we are today.

“We will be sad to say goodbye to a great colleague and friend who has built a fantastic leadership team. Chris leaves a tremendous legacy and, on behalf of the entire company, we wish him all the best for his well-deserved retirement.”